Announcement

Canaan’s
12th fund

Fresh capital to continue supporting bold ideas and the incredible people who make them happen.

Read the news

Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Announcement

Canaan’s
12th fund

>Astra

Fresh capital to continue supporting bold ideas and the incredible people who make them happen.

Read the news

Experience

A fine
balance

>The RealReal

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Berkshire Grey

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

Byron Ling: Doubling down on Papa – Why COVID was the shock we needed to improve care for older adults

Papa is a company we partnered with back in 2019 to lead their Series A. Since that investment, not only has the team’s expertise and tech matched...
Highlight

Endpoints News: Why do some targeted cancer therapies stop working? For Tyra, that's the $106M question

Targeted cancer therapies can be quite effective. Until, for some patients, the cancer mutates, and the treatment stops working. Enter Tyra.
Highlight

Laura Chau: Announcing our investment in Clutch

Clutch is building the premier vertically-integrated auto retailer in Canada.
Highlight

CNBC: Aeva CEO Soroush Salehian on taking the company public via SPAC

Soroush Salehian, Aeva co-founder and CEO, joins “Squawk Alley” as the company goes public to discuss what differentiates it from other Lidar brands.